GEO Investing

Sanuwave Health (OTCCB:SNWV) ($1.43) completed a reverse merger in 2009. At the time of the reverse merger the company was generating annual revenues of around $1 million through the sale of a medical device used to speed up tissue regeneration […]

Navidea Biopharmaceuticals (NAVB) is one of the most attractive short opportunities we have seen in some time. The company resubmitted its long-awaited drug candidate, Lymphoseek, to the FDA on October 31, 2012. Any “emotional” pop in NAVB’s share price that […]